Gadonanostructures as Magnetic Resonance Imaging Contrast Agents

Chemistry of Nanocarbons

Volumn , Issue , 2010, Pages 287-300

  Ananta, Jeyarama S ^a   Wilson, Lon J ^a  

^a RICE UNIVERSITY   (United States)

Author keywords

Gadofullerenes relaxation mechanism; Gadolinium ions, trapped within biologically stable carbon cage; Gadonanostructures as magnetic resonance imaging contrast agents; Gadonanostructures advantages as MRI contrast agent synthons; Gadonanotubes as MRI contrast agents and single walled carbon nanotubes (SWNTs); High spin paramagnetic Gd3+ ion effective T1 relaxation agent in MRI; Magnetic resonance imaging (MRI) noninvasive imaging modalities in diagnostic medicine and biomedical research; Molecular rotation and proton exchange rate parameters affecting MRI CAs relaxation properties; Nanoscale building blocks of carbonnanotechnology C60 fullerene, SWNT, gadofullerene; Temperature dependent relaxivity studies of gadonanotubes and proton exchange rate

Indexed keywords

EID: 84873426406     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470660188.ch11     Document Type: Chapter

References (46)

1. P. Mansfield, Snapshot magnetic resonance imaging. Angew. Chem., Int. Ed., 43, 5456-5464 (2004).
2. A. E. Merbach, E. Toth, Editors, The Chemistry of Contrast Agents in Medical Magnetic Resonance Imaging. 471 pp. (2001).
3. P. Caravan, J.J. Ellison, T.J. McMurry, R.B. Lauffer, Gadolinium(III) Chelates as MRI Contrast Agents: Structure, Dynamics, and Applications. Chem. Rev., 99, 2293-2352 (1999).
4. R.B. Lauffer, Paramagnetic metal complexes as water proton relaxation agents for NMR imaging: theory and design. Chem. Rev., 87, 901-927 (1987).
5. A.D. Nunn, K.E. Linder, M.F. Tweedle, Can receptors be imaged with MRI agents?. Q J Nucl Med, 41, 155-162 (1997).
6. H.W. Kroto, J.R. Heath, S.C. O'Brien, R.F. Curl, R.E. Smalley, C60: buckminsterfullerene. Nature, 318, 162-163 (1985).
7. P.M. Ajayan, Nanotubes from Carbon. Chem. Rev., 99, 1787-1799 (1999).
8. K.B. Hartman, L.J.Wilson, M.G. Rosenblum, Detecting and treating cancer with nanotechnology. Mol. Diagn. Ther., 12, 1-14 (2008).
9. C.R. Martin, P. Kohli, The emerging field of nanotube biotechnology. Nat. Rev. Drug Discovery, 2, 29-37 (2003).
10. J.M. Ashcroft, K.B. Hartman, K.R. Kissell, Y. Mackeyev, S. Pheasant, S. Young, P.A.W. Van der Heide, A.G. Mikos, L.J. Wilson, Single-molecule I2@US-tube nanocapsules: a new X-ray contrast-agent design. Adv. Mater., 19, 573-576 (2007).
11. K.B. Hartman, D.K. Hamlin, S.D.Wilbur, L.J.Wilson, 211AtCl@US-tube nanocapsules: a new concept in radiotherapeutic-agent design. Small, 3, 1496-1499 (2007).
12. S. Laurent, L.Vander Elst, R.N. Muller, Comparative study of the physicochemical properties of six clinical low molecular weight gadolinium contrast agents. Contrast Media Mol. Imaging, 1, 128-137 (2006).
13. M.A. Perazella, Nephrogenic systemic fibrosis, kidney disease, and gadolinium: is there a link?. Clin. J. Am. Soc. Nephrol., 2, 200-202 (2007).
14. Y. Mackeyev, K.B. Hartman, J.S. Ananta, A.V. Lee, L.J. Wilson, Catalytic synthesis of amino acid and peptide derivatized gadonanotubes. J. Am. Chem. Soc., 131, 8342-8343 (2009).
15. Z. Ou, B.Wu, D. Xing, F. Zhou, H.Wang, Y. Tang, Functional single-walled carbon nanotubes based on an integrin alpha vbeta 3 monoclonal antibody for highly efficient cancer cell targeting. Nanotechnology, 20, 105102/1-105102/7 (2009).
16. A.A. Bhirde, V. Patel, J. Gavard, G. Zhang, A.A. Sousa, A. Masedunskas, R.D. Leapman, R. Weigert, J.S. Gutkind, J.F. Rusling, Targeted killing of cancer cells in vivo and in vitro with EGF-directed carbon nanotube-based drug delivery. ACS Nano, 3, 307-316 (2009).
17. D. Pantarotto, J.P. Briand, M. Prato, A. Bianco, Translocation of bioactive peptides across cell membranes by carbon nanotubes. Chem. Commun., 1, 16-17 (2004).
18. B. Sitharaman, L.A. Tran, Q.P. Pham, R.D. Bolskar, R. Muthupillai, S.D. Flamm, A.G. Mikos, L.J.Wilson, Gadofullerenes as nanoscale magnetic labels for cellular MRI. Contrast Media Mol. Imaging, 2, 139-146 (2007).
19. N.W.S. Kam, T.C. Jessop, P.A.Wender, H. Dai, Nanotube molecular transporters: internalization of carbon nanotube-protein conjugates into mammalian cells. J. Am. Chem. Soc., 126, 6850-6851 (2004).
20. L.L. Dugan, D.M. Turetsky, C. Du, D. Lobner, M. Wheeler, C.R. Almli, C.K.F. Shen, T.Y. Luh, D.W. Choi, T.S. Lin, Carboxyfullerenes as neuroprotective agents. Proc. Natl. Acad. Sci. U. S. A., 94, 9434-9439 (1997).
21. M. Mikawa, H. Kato, M. Okumura, M. Narazaki, Y. Kanazawa, N. Miwa, H. Shinohara, Paramagnetic Water-Soluble Metallofullerenes Having the highest relaxivity for MRI contrast agents. Bioconjugate Chem., 12, 510-514 (2001).
22. L.J. Wilson, Medical applications of fullerenes and metallofullerenes. Electrochem. Soc. Interface, 8, 24-28 (1999).
23. E. Toth, R.D. Bolskar, A. Borel, G. Gonzalez, L. Helm, A.E. Merbach, B. Sitharaman, L.J.Wilson,Water-soluble gadofullerenes: toward high-relaxivity, pH-responsive MRI contrast agents. J. Am. Chem. Soc., 127, 799-805 (2005).
24. S. Zhang, D. Sun, X. Li, F. Pei, S. Liu, Synthesis and solvent enhanced relaxation property of water-soluble endohedral metallofullerenols. Fullerene Sci. Technol., 5, 1635-1643 (1997).
25. R.D. Bolskar, A.F. Benedetto, L.O. Husebo, R.E. Price, E.F. Jackson, S. Wallace, L.J. Wilson, J.M. Alford, First soluble M@C60 derivatives provide enhanced access to metallofullerenes andpermit in vivo evaluation of Gd@C60[C(COOH)2]10 as a MRI contrast agent. J. Am. Chem. Soc., 125, 5471-5478 (2003).
26. S. Stevenson, G. Rice, T. Glass, K. Harlch, F. Cromer, M.R. Jordan, J. Craft, E. Hadju, R. Bible, M.M. Olmstead, K. Maltra, A.J. Fisher, A.L. Balch, H.C. Dorn, Small-bandgap endohedral metallofullerenes in high yield and purity. Nature, 401, 55-57 (1999).
27. L. Dunsch, S. Yang, Metal nitride cluster fullerenes: their current state and future prospects. Small, 3, 1298-1320 (2007).
28. R.P. Fatouros, F.D. Corwin, Z.J. Chen, B.C. William, J.L. Tatum, B. Kettenmann, Z. Ge, H.W. Gibson, J.L. Russ, A.P. Leonard, J.C. Duchamp, H.C. Dorn, In vitro and in vivo imaging studies of a new endohedral metallofullerene nanoparticle. Radiology, 240, 756-764 (2006).
29. C.Y. Shu, E.Y. Zhang, J.F. Xiang, C.F. Zhu, C.R.Wang, X.L. Pei, H.B. Han, Aggregation studies of the water-soluble gadofullerene magnetic resonance imaging contrast agent: [Gd@C82O6(OH)16(NHCH2CH2COOH)8]x. J. Phys. Chem. B, 110, 15597-15601 (2006).
30. E.Y. Zhang, C.Y. Shu, L. Feng, C.R.Wang, Preparation and characterization of two new watersoluble endohedral metallofullerenes as magnetic resonance imaging contrast agents. J. Phys. Chem. B, 111, 14223-14226 (2007).
31. K. Micskei, L. Helm, E. Brucher, A.E. Merbach, Oxygen-17 NMR study of water exchange on gadolinium polyaminopolyacetates [Gd(DTPA)(H2O)]2- and [Gd(DOTA)(H2O)]- related to NMR imaging. Inorg. Chem., 32, 3844-3850 (1993).
32. D.M. Guldi, H. Hungerbuehler, K.D. Asmus, Unusual redox behavior of a water soluble malonic acid derivative of C60: evidence for possible cluster formation. J. Phys. Chem., 99, 13487-13493 (1995).
33. B. Sitharaman, R.D. Bolskar, I. Rusakova, L.J. Wilson, Gd@C60[C(COOH)2]10 and Gd@C60(OH)x: Nanoscale aggregation studies of two metallofullerene MRI contrast agents in aqueous solution. Nano Lett., 4, 2373-2378 (2004).
34. H. Kato, Y. Kanazawa, M. Okumura, A. Taninaka, T. Yokawa, H. Shinohara, Lanthanoid endohedral metallofullerenols for MRI contrast agents. J. Am. Chem. Soc., 125, 4391-4397 (2003).
35. I.F. Tannock, D. Rotin, Acid pH in tumors and its potential for therapeutic exploitation. Cancer Res, 49, 4373-4384 (1989).
36. S. Aime, S.G. Crich, M. Botta, G. Giovenzana, G. Palmisano, M. Sisti, A macromolecular Gd (III) complex as pH-responsive relaxometric probe for MRI applications. Chem. Commun., 16, 1577-1578 (1999).
37. S. Laus, B. Sitharaman, E. Toth, R.D. Bolskar, L. Helm, S. Asokan, M.S.Wong, L.J.Wilson, A.E. Merbach, Destroying gadofullerene aggregates by salt addition in aqueous solution of Gd@C60 (OH)x and Gd@C60[C(COOH2)]10. J. Am. Chem. Soc., 127, 9368-9369 (2005).
38. S. Laus, B. Sitharaman, E. Toth, R.D. Bolskar, L. Helm, L.J. Wilson, A.E. Merbach, Understanding paramagnetic relaxation phenomena for water-soluble gadofullerenes. J. Phys. Chem. C, 111, 5633-5639 (2007).
39. C.J. Gannon, P. Cherukuri, B.I.Yakobson, L. Cognet, J.S. Kanzius, C. Kittrell, R.B.Weisman, M. Pasquali, H.K. Schmidt, R.E. Smalley, S.A. Curley, Carbon nanotube-enhanced thermal destruction of cancer cells in a noninvasive radiofrequency field. Cancer, 110, 2654-2655 (2007).
40. C. Zavaleta, A. de la Zerda, Z. Liu, S. Keren, Z. Cheng, M. Schipper, X. Chen, H. Dai, S.S. Gambhir, Noninvasive Raman spectroscopy in living mice for evaluation of tumor targeting with carbon nanotubes. Nano Lett., 8, 2800-2805 (2008).
41. B. Sitharaman, L.J. Wilson, Gadofullerenes and gadonanotubes: a new paradigm for highperformance magnetic resonance imaging contrast agent probes. J. Biomed. Nanotechnol., 3, 342-352 (2007).
42. B. Sitharaman, K.R. Kissell, K.B. Hartman, L.A. Tran, A. Baikalov, I. Rusakova, Y. Sun, H.A. Khant, S.J. Ludtke, W. Chiu, S. Laus, E. Toth, L. Helm, A.E. Merbach, L.J. Wilson, Superparamagnetic gadonanotubes are high-performance MRI contrast agents. Chem. Commun., 31, 3915-3917 (2005).
43. Z. Gu, H. Peng, R.H. Hauge, R.E. Smalley, J.L. Margrave, Cutting single-wall carbon nanotubes through fluorination. Nano Lett., 2, 1009-1013 (2002).
44. A. Striolo, The Mechanism of Water Diffusion in Narrow Carbon Nanotubes. Nano Lett., 6, 633-639 (2006).
45. K.B. Hartman, S. Laus, R.D. Bolskar, R. Muthupillai, L. Helm, E. Toth, A.E. Merbach, L.J. Wilson, Gadonanotubes as Ultrasensitive pH-Smart Probes for Magnetic Resonance Imaging. Nano Lett., 8, 415-419 (2008).
46. T.H. Cheng, T.W. Lee, J.S. Jeng, C.M.Wu, G.C. Liu, M.Y.N. Chiang, Y.M.Wang, Synthesis and characterization of a novel paramagnetic macromolecular complex [Gd(TTDASQ-protamine)]. Dalton Trans., 43, 5149-5155 (2006).